pre-coded pbpk model structures (Simcyp)
90
Structured Review
Simcyp
pre-coded pbpk model structures
Pre Coded Pbpk Model Structures, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+model+code/population+pbpk+simulator/pmc08894322-179-12-0
Average 90 stars, based on 1 article reviews
Pre Coded Pbpk Model Structures, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+model+code/population+pbpk+simulator/pmc08894322-179-12-0
Average 90 stars, based on 1 article reviews
pre-coded pbpk model structures - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence"
Article Title: Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence
Journal: Frontiers in Digital Health
doi: 10.3389/fdgth.2022.799341
Figure Legend Snippet: Illustration of the evaluation of pharmacokinetic data using NLME and PBPK models as well as ANNs. Created with www.Biorender.com .
Techniques Used:
Related Articles
other:Article Title: Cytokine Dynamics in Action: A Mechanistic Approach to Assess Interleukin 6 Related Therapeutic Protein-Drug-Disease Interactions. Article Snippet: Understanding cytokinerelated therapeutic protein–drug interactions (TPDI) is crucial for effective medication management in conditions characterized by elevated inflammatory responses.. Recent FDA and ICH guidelines highlight a systematic, riskbased approach for evaluating these interactions, emphasizing the need for a thorough mechanistic understanding of TPDIs.. This study integrates the physiologically based pharmacokinetic (PBPK) model for TP (specifically interleukin6, IL6) with smallmolecule drug PBPK models to elucidate cytokinerelated TPDI mechanistically. Article Title: Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling. Article Snippet: Further, implications of such data for the prediction of mAb disposition and disease effects were assessed using the Article Title: Physiologically-based pharmacokinetic modelling guided dose evaluations of nirmatrelvir/ritonavir in renal impairment for the management of COVID-19. Article Snippet: Funding information Part of this work was supported by the Joseph Lim Boon Tiong Urology Cancer Research (A0002678-01-00) provided to Eric Chun Yong Chan and the NMRC research training fellowship (MOH-RTF21nov-0005) provided to Tat Ming Ng.. Abstract We aimed to address factors contributing to the pharmacokinetic changes of nirmatrelvir/ritonavir in renal impaired (RI) patients and recommend dosing adjustment via a physiologically-based pharmacokinetic (PBPK) modelling approach.. A PBPK model of nirmatrelvir/ritonavir was developed via Simcyp Simulator. Article Title: Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82003712, 82104306; Scientific Research Fund of Hunan Provincial Education Department, Grant/Award Number: 21B0013; Hunan Provincial Natural Science Foundation of China, Grant/Award Numbers: 2021JJ40815, 2022JJ40694 Aims: Ampicillin is frequently used in neonates for the treatment of sepsis and as an intrapartum prophylaxis option for Group B Streptococcus.. Pharmacokinetic data to guide ampicillin dosing in neonates and during the intrapartum period are limited.. The objective of this study was to build a physiologically-based pharmacokinetic (PBPK) model to characterize the disposition of ampicillin in neonates and foetuses and to inform corresponding optimal dosing regimens. Clinical Proteomics:Article Title: Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women Article Snippet: .. The Simcyp population‐based Concentration Assay:Article Title: Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women Article Snippet: .. The Simcyp population‐based |